ClinicalTrials.Veeva

Menu

Efficacy Study of Multiple Micro Nutrients Supplementation (Babytop)

S

Sarihusada

Status

Unknown

Conditions

Anemia, Iron-deficiency

Treatments

Dietary Supplement: Maltodextrin and Lactose
Dietary Supplement: Multi-micronutrients

Study type

Interventional

Funder types

Industry

Identifiers

NCT01840384
CT.01.2012

Details and patient eligibility

About

This study is initiated to investigate the effect of multi micronutrient supplementation for 12 months on serum haemoglobin level in Indonesian young children.

Enrollment

239 estimated patients

Sex

All

Ages

8 to 10 months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Apparently healthy Indonesian infants
  • Age 8-10 month at baseline visit
  • Willing to take 2 sachets of study product per day
  • Planning to reside in the study area during the next 14-16 months
  • Written informed consent by parent(s) or legally acceptable representative (in ICF there is statement that both are agree that child participate in the study)

Exclusion criteria

  • Haemoglobin < 8 g/dL at screening visit*.

  • Significant congenital abnormality which according to investigator's clinical judgement will interfere the study conduct and assessment

  • Any known conditions likely to affect nutrient absorption diagnosed by the child's physician

  • Disorders requiring a special diet (such as food intolerance or food allergy or complaints such as reflux, constipation and cramps for which special formula is required).

  • Any other current or previous illnesses/conditions or intervention which according to investigator's clinical judgement could interfere the study conduct and assessment (e.g. chronic illness or physical or mental handicaps)

  • Regular use of MMN supplements syrup (every day in > 1 week) within two weeks prior to entry into the study.

  • Not intending to use micronutrient supplements during the study

  • Participation in any other studies involving similar investigational or marketed products concomitantly or within two weeks prior to entry into the study.

  • Premature birth (gestational age <37 weeks)

  • Low birth weight (< 2500 g)

  • Severely under nutrition indicated by any of the following criteria: severely stunted: HAZ < -3 SD; severely underweight WAZ <-3 SD; wasted: WHZ <-2 SD

    *Subject with haemoglobin level (finger prick blood sample) at screening visit between 8-10 g/dL will be given iron syrup supplementation for 1 month. Thereafter, haemoglobin level (whole blood sample) will be checked at baseline visit:

  • If Hb > 10 g/dL, subject is eligible for randomisation

  • If Hb < 10 g/dL, subject is not eligible for randomisation and will be given iron syrup supplementation for 2 months

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

239 participants in 2 patient groups, including a placebo group

Multi-micronutrients
Experimental group
Description:
Multi-micronutrients
Treatment:
Dietary Supplement: Multi-micronutrients
Maltodextrin and Lactose
Placebo Comparator group
Description:
Placebo contained maltodextrin and lactose
Treatment:
Dietary Supplement: Maltodextrin and Lactose

Trial contacts and locations

1

Loading...

Central trial contact

Tonny Sundjaya, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems